Petronius Development Group Effective Treatment of Autoimmune Diseases

Autoimmune Diseases: The Future is a Normal Life with PDG Treatments

---

PDG Medical-- Our Breakthroughs

       The PDG Medical and Pharmaceutical discoveries represent a PARADIGM SHIFT in autoimmune disease treatment, because this is the first ever treatment aimed as suppressing the causative agent of these diseases.
       With our discovery of the causative agent for autoimmune diseases, drugs can then attack and suppress the diseases. PDG's approach to treating autoimmune diseases is pure medical science and functions in exactly the same way as bacteria is suppressed with an antibiotic such as penicillin.
• The infectious agent which causes autoimmune disease has been identified through PDG's over 25 years of research.
• The infectious agent is very stealthy which has prevented prior identification.
• An effective drug and treatment regimen have been developed which totally suppresses all manifestations of autoimmune diseases.
• The suppression is almost immediate within a few days from the first treatment and continues as long as the treatment is maintained.
• There is no direct evidence or link between autoimmune disease and dietary or environmental changes and any variation in the signs and symptoms are purely anecdotal or coincidental.

 

---

PDG Medical-- The Future

• Our discovery of a causative agent and the drug treatment regimen to control that agent are to autoimmune disease what the understanding of infectious pathogens as cause and penicillin & antibiotics as treatment are to infection and general disease.
• PDG is currently seeking funding for our new medical innovation. Unfortunately funds usually flow to the traditional, which support the old theory (and ineffective treatments) because they are safe for investors.
• Although Case Studies are underway, they are very limited due to the high costs of Clinical Supervision and drugs.
• With additional funding, PDG can take our breakthrough discoveries to the next level of broader Clinical Trials and FDA/EMA* approval.
• Once the new treatments receive FDA/EMA* approval most patients with autoimmune disease will be able to return to a normal, pre-disease life (1).
• The manifestiation of the disease in different parts of the body is easily explained. What ever system or organ the disease infects, that is the primary focus of distress. That is why so many different symptoms can be the same disease.
(1) Tissues previously destroyed by disease can not be restored.
*EMA is the European Medical Agency